Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KWA-0711 Dose-tapering in Chronic Constipation
NCT01937663Phase 2Completed
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mizagliflozin in chronic constipation, sponsored by Kissei Pharmaceutical Co., Ltd.. Status: completed.
02
Drugs
mizagliflozin
03
Conditions
chronic constipation
Beyond the preview
Go deeper on NCT01937663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01937663.